glp-1 9 in 1 Glucagon-like peptide-1 cleavage product GLP-1(9–36) reduces neuroinflammation from stroke via the activation of insulin-like growth factor receptor astrocytes Glucagon-Like Peptide 1, GLP-1 (9-36),

ChaudhuriAGhanimHVoraMSiaCLKorzeniewskiKDhindsaSet alExenatide exerts a potent antiinflammatory effect

and a detailed discussion of your tolerance to high-fat or high-fiber foods

Taken together, the figure highlights a key mechanistic principle underlying the therapeutic rationale for multi-agonist strategies: while GLP-1R monotherapy achieves meaningful metabolic and hepatic benefits exclusively through indirect, systemic pathways, the addition of GIPR and - most importantly - GCGR co-agonism introduces complementary and increasingly direct hepatic mechanisms, providing the pharmacological basis for the superior efficacy observed with dual and triple agonists in MASLD/MASH

Avoiding high-fat meals can minimize nausea and delayed gastric emptying